Covivio (COV) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
20 Feb, 2026Executive summary
Achieved strong operating and financial performance in 2025, with recurring net result per share up 6.4% to €4.75 and NAV per share up 3.9% to €82.9.
Maintained a diversified, high-quality portfolio focused on central European locations, hospitality, and German residential assets.
Strategic capital rotation towards core assets and increased exposure to hotels, especially in Southern Europe.
Entered 2026 with positive momentum and guidance for further growth, targeting a 4% increase in recurring result per share.
Portfolio value grew 2.1% like-for-like to €16.0bn (Group share), with high occupancy rates and long lease terms.
Financial highlights
Rental revenues grew 3.7%, driven by 3.4% like-for-like growth, with office rents up 3.4% and hotels up 1.6% despite negative base effects.
Recurring net income (adjusted EPRA Earnings) up 10% to €526.5m; recurring net result per share up 6.4% to €4.75.
Dividend payment increased by 7% to €3.75/share, representing a 7% yield, to be paid in two installments.
Net debt/EBITDA improved to 10.7x; EPRA LTV at 38.9% (potentially below 40% including pending disposals).
Net rental income rose 10% year-over-year to €526.5m; operating income increased 8% to €615.7m.
Outlook and guidance
2026 guidance targets 4% growth in recurring result per share, supported by operating performance, asset management, and ancillary revenues.
Strategic focus on increasing hotel exposure to one-third of the portfolio and enhancing centrality of office assets.
Guidance includes headwinds from CB21 lease indexation and higher financing costs, expected to reverse in 2027.
Latest events from Covivio
- Revenue up 4.8% with 2025 guidance confirmed; strong operations and ESG leadership.COV
Q3 202520 Feb 2026 - Recurring net result up 3.3%, guidance raised, and hotel exposure increased to 20%.COV
H1 20243 Feb 2026 - Recurring net result up 14% and 2025 guidance raised on strong H1 and market recovery.COV
H1 202527 Jan 2026 - Q1 2025 revenue up 5.4%, with high occupancy and guidance and dividend increase confirmed.COV
Q1 202527 Jan 2026 - Revenue up 6.8% like-for-like, occupancy at 97.3%, and €391m in disposals signed.COV
Q3 202419 Jan 2026 - Balanced growth, centrality, and ESG leadership drive portfolio transformation to 2030.COV
CMD 202412 Jan 2026 - Recurring net income up 10% and dividend up 6%, with 2025 guidance for further growth.COV
Q4 202417 Dec 2025